|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 73, 293-296, Copyright © 1977 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
JN Galgiani and DA Stevens
Successful treatment of fungal endocarditis is being described with
increasing frequency. Two patients, previously reported as free of disease
by two different groups of investigators, subsequently died in our
institutions with evidence of continued disease. Both patients had been
receiving antifungal chemotherapy at the time their case histories were
reported. The lack of clinical signs and symptoms in fungal endocarditis,
the suppression of manifestations of infection by chemotherapy, and the
uncertain reliability of laboratory aids led us to suggest guidelines in
reporting results of therapuetic regimens. These include avoidance of terms
implying cure in patients who are concurrently maintained on chemotherapy,
indication of attempts to evaluate fungemia, and minimum follow-up of 1-2
years' duration. The potential utility of serologic studies is illustrated
by the course of one of these patients.
ARTICLES
Fungal endocarditis: need for guidelines in evaluating therapy. Experience with two patients previously reported
This article has been cited by other articles:
![]() |
A. U. Gullu, M. Akcar, A. Arnaz, and M. Kizilay Candida parapsilosis tricuspid native valve endocarditis: 3-year follow-up after surgical treatment Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 513 - 514. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |